The effect of age on the response of the rat brains to continuous β-amyloid infusion

Brain Research

Volumn 889, Issue 1-2, 2001, Pages 303-307

  Nag, Subodh ^a   Tang, Fai ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Amyloid; Aging; Choline acetyltransferase; Memory; Somatostatin

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; NEUROPEPTIDE Y; SOMATOSTATIN; SUBSTANCE P;

ADOLESCENT; AGE; AGED; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; MEMORY; MENTAL DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; RAT; SOMATOSTATIN BLOOD LEVEL;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; BRAIN CHEMISTRY; CHOLINE O-ACETYLTRANSFERASE; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; NEUROTOXINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035910370     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03172-3     Document Type: Article

References (41)

1. Alzheimer's disease: The relationship between the density of senile plaques, neurofibrillary tangles and A4 protein in human patients
2. Effect of neuropeptides on cognitive function
3. A synaptic model of memory: Long-term potentiation in the hippocampus
4. Acetylcholine: A neurotransmitter for learning and memory?
5. A survey of substance P, somatostatin, and neurotensin levels in aging in the rat and human central nervous system
6. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa
7. Correlations between water maze performance and cortical somatostatin mRNA and high-affinity binding sites during ageing in rats
8. A rapid radiochemical method for the determination of choline acetyltransferase
9. Rodent models of Alzheimer's disease: Rat A beta infusion approaches to amyloid deposits
10. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity
11. Similarities between beta amyloid peptides 1-40 and 40-1: Effects on aggregation, toxicity in vitro, and injection in young and aged rats
12. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain
13. +-dependent glutamate uptake in rat hippocampal astrocyte cultures
14. Impairments of long-term potentiation in hippocampal slices of β-amyloid-infused rats
15. Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein-infused rats
16. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P
17. + homeostasis and cell death
18. Amyloid plaque core protein in Alzheimer disease and Down syndrome
19. Changes in brain somatostatin in memory-deficient rats: Comparison with cholinergic markers
20. Developments of a water-maze procedure for studying spatial learning in the rat
21. Cholinergic lesions of the rat brain by ibotenic acid and 192 IgG-saporin: Effects on somatostatin, substance P and neuropeptide Y levels in the cerebral cortex and the hippocampus
22. Reduction in somatostatin and substance P levels and choline acetyltransferase activity in the cortex and hippocampus of the rat after chronic intracerebroventricular infusion of β-amyloid (1-40)
23. Facilitation of tunnel maze performance by systemic injection of the neurokinin substance P
24. Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration
25. Beta-amyloid protein-induced Alzheimer's disease animal model
26. Experimental techniques for developing new drugs acting on dementia (10)-Alzheimer's disease animal model induced by beta-amyloid protein
27. Vulnerability of small GABAergic neurons to human beta-amyloid pentapeptide
28. Normal and abnormal biology of the beta-amyloid precursor protein
29. Facilitation of learning by post-trial injection of substance P into the medial septal nucleus
30. NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by beta-amyloid protein in rats
31. Solvent effects on beta protein toxicity in vivo
32. Age-related changes in the contents of neuropeptides in the rat brain and pituitary
33. Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: Implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo
34. Improvement by nefiracetam of beta-amyloid-(1-42)-induced learning and memory impairments in rats
35. Propentofylline improves learning and memory deficits in rats induced by beta-amyloid protein-(1-40)
36. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining
37. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
38. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease
39. Alteration in the levels of thyrotropin releasing hormone, substance P and enkephalins in the spinal cord, brainstem, hypothalamus and midbrain of the Wobbler mouse at different stages of the motoneuron disease
40. Selective lesion of the cholinergic basal forebrain causes a loss of cortical neuropeptide Y and somatostatin neurons